A new era for biotech patents? Empirical and theoretical considerations on the current patent dilemma
During the last two decades, the genomics revolution has contributed enormously to the development of novel research approaches in the field of biological sciences. We have seen the development of new biotechnological tools capable of modifying organisms in order to perform specific tasks designing...
| Autor: | |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | España |
| Recursos: | Universitat Pompeu Fabra |
| Repositorio: | Repositorio Digital de la UPF |
| OAI Identifier: | oai:repositori.upf.edu:10230/72375 |
| Acesso em linha: | https://hdl.handle.net/10230/72375 http://dx.doi.org/10.15168/2284-4503-787 |
| Access Level: | acceso abierto |
| Palavra-chave: | Gene patents Genetic engineering Biotechnology Patents CoViD-19 |
| Resumo: | During the last two decades, the genomics revolution has contributed enormously to the development of novel research approaches in the field of biological sciences. We have seen the development of new biotechnological tools capable of modifying organisms in order to perform specific tasks designing and assembling novel biological components. All these scientific and biotechnological innovations present also a substantial challenge for the law and especially for intellectual property rights. In particular -as a consequence of relevant patent case law in the United States and Europe affecting precision medicine- the debate on the possible future of biotech patents gained increasing momentum. Considering this multifaceted scenario, the purpose of this article is to analyse the impact of various judicial decisions with respect to patents subject-matter eligibility and the prosecution of biotech-related patent applications. |
|---|